Christopher Heery is CHIEF MEDICAL OFFICER of Arcellx, Inc.. Currently has a direct ownership of 9,278 shares of ACLX, which is worth approximately $512,052. The most recent transaction as insider was on Jun 12, 2024, when has been sold 20,000 shares (Common Stock) at a price of $55.58 per share, resulting in proceeds of $1,111,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.28K
3.8% 3M change
19.03% 12M change
Total Value Held $512,052

Christopher Heery Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
SELL
Open market or private sale
$1,111,600 $55.58 p/Share
20,000 Reduced 68.31%
9,278 Common Stock
Jun 12 2024
BUY
Exercise of conversion of derivative security
$212,800 $10.64 p/Share
20,000 Added 40.59%
29,278 Common Stock
May 01 2024
SELL
Open market or private sale
$947,642 $52.16 p/Share
18,168 Reduced 67.03%
8,938 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
$114,095 $6.28 p/Share
18,168 Added 40.13%
27,106 Common Stock
Mar 26 2024
SELL
Open market or private sale
$378,066 $69.37 p/Share
5,450 Reduced 37.88%
8,938 Common Stock
Mar 26 2024
BUY
Exercise of conversion of derivative security
$34,226 $6.28 p/Share
5,450 Added 27.47%
14,388 Common Stock
Mar 22 2024
SELL
Open market or private sale
$2,929,882 $70.83 p/Share
41,365 Reduced 82.23%
8,938 Common Stock
Mar 22 2024
BUY
Exercise of conversion of derivative security
$125,600 $6.28 p/Share
20,000 Added 28.45%
50,303 Common Stock
Feb 12 2024
SELL
Open market or private sale
$191,252 $64.46 p/Share
2,967 Reduced 8.92%
30,303 Common Stock
Feb 09 2024
SELL
Open market or private sale
$233,819 $63.4 p/Share
3,688 Reduced 9.98%
33,270 Common Stock
Feb 08 2024
SELL
Open market or private sale
$215,274 $62.29 p/Share
3,456 Reduced 8.55%
36,958 Common Stock
Feb 07 2024
BUY
Exercise of conversion of derivative security
-
22,555 Added 35.82%
40,414 Common Stock
Jan 04 2024
SELL
Open market or private sale
$419,941 $55.27 p/Share
7,598 Reduced 29.85%
17,859 Common Stock
Jan 03 2024
BUY
Exercise of conversion of derivative security
-
16,519 Added 39.35%
25,457 Common Stock
Dec 18 2023
SELL
Open market or private sale
$6,117,600 $50.98 p/Share
120,000 Reduced 93.9%
7,795 Common Stock
Dec 18 2023
BUY
Exercise of conversion of derivative security
$753,600 $6.28 p/Share
120,000 Added 48.43%
127,795 Common Stock
Aug 04 2023
SELL
Open market or private sale
$106,140 $35.38 p/Share
3,000 Reduced 27.79%
7,795 Common Stock
Aug 04 2023
BUY
Exercise of conversion of derivative security
$45,000 $15.0 p/Share
3,000 Added 21.75%
10,795 Common Stock
Jul 03 2023
SELL
Open market or private sale
$95,250 $31.75 p/Share
3,000 Reduced 27.79%
7,795 Common Stock
Jul 03 2023
BUY
Exercise of conversion of derivative security
$45,000 $15.0 p/Share
3,000 Added 21.75%
10,795 Common Stock
May 10 2023
SELL
Open market or private sale
$99,260 $45.18 p/Share
2,197 Reduced 21.99%
7,795 Common Stock
May 09 2023
SELL
Open market or private sale
$22,500 $45.0 p/Share
500 Reduced 4.77%
9,992 Common Stock
May 05 2023
SELL
Open market or private sale
$54,000 $45.0 p/Share
1,200 Reduced 10.26%
10,492 Common Stock
May 03 2023
SELL
Open market or private sale
$129,420 $43.14 p/Share
3,000 Reduced 20.42%
11,692 Common Stock
May 03 2023
BUY
Exercise of conversion of derivative security
$45,000 $15.0 p/Share
3,000 Added 16.96%
14,692 Common Stock
CH

Christopher Heery

CHIEF MEDICAL OFFICER
Gaithersburg, MD

Track Institutional and Insider Activities on ACLX

Follow Arcellx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACLX shares.

Notify only if

Insider Trading

Get notified when an Arcellx, Inc. insider buys or sells ACLX shares.

Notify only if

News

Receive news related to Arcellx, Inc.

Track Activities on ACLX